Detail akcie OraSure Tech online

Business Summary: OraSure Technologies, Inc. provides point-of-care and home diagnostic tests and sample management solutions. The Company's product portfolio is divided into diagnostics products and sample management solutions. Its business consists of the development, manufacture, marketing and sale of diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. Its diagnostic products include tests for diseases including COVID-19, HIV, Hepatitis C and Syphilis that are performed on a rapid basis at the point of care. Its business also includes sample management solutions and services that are used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.
Financial Summary: BRIEF: For the six months ended 30 June 2025, OraSure Technologies Inc revenues decreased 44% to $61.2M. Net loss increased from $4.2M to $35.7M. Revenues reflect Net product and service revenues -Molecular Products segment decrease of 64% to $8.5M, Net product and services revenues - COVID-19 segment decrease of 35% to $27.3M, United States segment decrease of 55% to $40.2M, Other Regions segment decrease of 77% to $2M.